Stocks
Calidi Biotherapeutics, Inc.CLDI
AMEXHealthcareBiotechnology$0.64
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing oncolytic virus therapies for solid tumors, with a lead candidate targeting advanced cancers. Its proprietary platforms aim to deliver tumor-selective viral replication while minimizing systemic toxicity. Investors track the stock for its early-stage pipeline and upcoming clinical data readouts.
52W Range: $0.62-$27.04
Congressional Interest in Calidi Biotherapeutics, Inc. (CLDI)
No congressional trades have been disclosed for Calidi Biotherapeutics, Inc. (CLDI) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading CLDI?
No congressional trades found for this stock.